Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 501–600 of 1,011
p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress
Marusyk, A., Wheeler, L. J., Mathews, C. K., & DeGregori, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01316-06 · Cited by 74
“Second, although the activation of DNA damage-signaling pathways during oncogene-induced hyperreplication leads to tumor-suppressive senescence (3, 30), these events should also select for mutations (such as in p53) that avoid senescence (4, 26, 58).”
BackgroundA neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis
Gao, Y., Mutter‐Rottmayer, E., Greenwalt, A., Goldfarb, D., Yan, F., Yang, Y., Martinez‐Chacin, R. C., Pearce, K. H., Tateishi, S., Major, M. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12105 · Cited by 80
ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion
Chen, W.-T., Ebelt, N. D., Stracker, T. H., Xhemalce, B., Van Den Berg, C. L., & Miller, K. M. (2015) · eLife · doi:10.7554/elife.07270 · Cited by 73
“…anti-cancer barriers to limit proliferation in response to, and in the presence of, DNA damage (Norbury and Zhivotovsky, 2004; Bartkova et al., 2005; Gorgoulis et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006; Vousden and Lane, 2007; Sherman et al., 2011; Roos and Kaina, 2013).”
BackgroundTranslational control and the cancer cell response to stress
Robichaud, N., & Sonenberg, N. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.007 · Cited by 70
Misawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets
Khamidullina, A. I., Abramenko, Y. E., Bruter, A. V., & Tatarskiy, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021263 · Cited by 81
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
Liberal, V., Ahlzén, H.-S. M., Liberal, J., Spruck, C., Widschwendter, M., McGowan, C. H., & Reed, S. I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102434108 · Cited by 83
PIG3: A novel link between oxidative stress and DNA damage response in cancer
Kotsinas, A., Aggarwal, V., Tan, E.-J., Levy, B., & Gorgoulis, V. G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.009 · Cited by 65
Loss of lamin B receptor is necessary to induce cellular senescence
Lukášová, E., Kovarˇík, A., Bacˇíková, A., Falk, M., & Kozubek, S. (2017) · Biochemical Journal · doi:10.1042/bcj20160459 · Cited by 69
Yu, S., Wang, X., Geng, P., Tang, X., Xiang, L., Lu, X., Li, J., Ruan, Z., Chen, J., Xie, G., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12405 · Cited by 72
Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Gaggioli, V., Lo, C. S. Y., Reverón-Gómez, N., Jasencakova, Z., Domènech, H., Nguyen, H. N., Sidoli, S., Tvardovskiy, A., Uruci, S., Slotman, J. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01167-z · Cited by 77
Replication stress as a driver of cellular senescence and aging
Herr, L. M., Schaffer, E. D., Fuchs, K. F., Datta, A., & Brosh, R. M. (2024) · Communications Biology · doi:10.1038/s42003-024-06263-w · Cited by 85
“Unresolved replication fork intermediates result in irreversible fork collapse or DSB formation at forks that drive senescence and aging 108 .”
BackgroundPremature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Khandanpour, C., Phelan, J. D., Vaßen, L., Schütte, J., Chen, R., Horman, S. R., Gaudreau, M., Krongold, J., Zhu, J., Paul, W. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.011 · Cited by 84
“Therefore, tumor cells must counteract cell death in order to survive (Bartek et al., 2007; Bartkova et al., 2007; Di Micco et al., 2006; Halazonetis et al., 2008).”
Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M. W., Dyson, N. J., & Wei, W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0092 · Cited by 80
Boyer, A.-S., Walter, D., & Sørensen, C. S. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.01.001 · Cited by 79
Shao, A.-W., Sun, H., Geng, Y., Peng, Q., Wang, P., Chen, J., Xiong, T., Cao, R., & Tang, J. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2015.150 · Cited by 83
Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile
Jing, F., Hu, X., Cao, Y., Xu, M., Wang, Y., Jing, Y., Hu, X., Gao, Y., & Zhu, Z. (2018) · IUBMB Life · doi:10.1002/iub.1748 · Cited by 76
“Recent studies have demonstrated that chromosomal instability in the early stage of cancer is caused by the pressure of DNA replication (43,44).”
BackgroundLabit, H., Goldar, A., Guilbaud, G., Douarche, C., Hyrien, O., & Marheineke, K. (2008) · BioTechniques · doi:10.2144/000113002 · Cited by 71
Endothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Zhang, B., Mehrotra, S., Ng, W. L., & Calvi, B. R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004581 · Cited by 74
“If this genotoxic stress is severe, however, the cells can enter a quiescent state known as senescence, or initiate programmed cell death (PCD), with one important type called apoptosis [3,4].”
BackgroundCdk2: a key regulator of the senescence control function of Myc
Hydbring, P., & Larsson, L. (2010) · Aging · doi:10.18632/aging.100140 · Cited by 81
“Depending on the type of lesion, DDR can cause activation of p53 via pathways involving the checkpoint kinases ATM and Chk2 or ATR and Chk1, which in turn induces p53 [19,20].”
BackgroundNucleotide Pool Depletion Induces G-Quadruplex-Dependent Perturbation of Gene Expression
Papadopoulou, C., Guilbaud, G., Schiavone, D., & Sale, J. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.039 · Cited by 71
“Replication stress, on the other hand, is emerging as an important feature of cancer cells, particularly in the early stages of their evolution (Bester et al., 2011; Di Micco et al., 2006; Halazonetis et al., 2008).”
BackgroundConnecting the Dots: From DNA Damage and Repair to Aging
Pan, M., Li, K., Lin, S., & Hung, W.-C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050685 · Cited by 80
“Previous studies showed that oncogene-induced senescence in fibroblasts is a DDR triggered by replication dysregulation, because of the elevated replication stress from unregulated proliferation [58,59].”
BackgroundSynergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer
Thurlings, I., Martínez-López, L. M., Westendorp, B., Zijp, M., Kuiper, R., Tooten, P., Kent, L. N., Leone, G., Vos, H. J., Burgering, B., et al. (2017) · Oncogene · doi:10.1038/onc.2016.251 · Cited by 73
Emerging Roles of p53 Related lncRNAs in Cancer Progression: A Systematic Review
Lin, T., Hou, P.-F., Meng, S., Chen, F., Jiang, T., Li, M.-L., Shi, M.-L., Liu, J.-J., Zheng, J.-N., & Bai, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33218 · Cited by 71
“Furthermore, GUARDIN expression is increased due to the activation of DNA damage response with DOXO or overexpression of the oncogenic H-RASV12 mutant in malignant cells and in untransformed adult foreskin fibroblasts [71].”
BackgroundDOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Leon, K. E., Buj, R., Lesko, E., Dahl, E. S., Chen, C.-W., Tangudu, N. K., Imamura-Kawasawa, Y., Kossenkov, A. V., Hobbs, R. P., & Aird, K. M. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202008101 · Cited by 70
“…senescence in human cells, it is possible that oncogenic stress, which is generally more robust and associated with a hyperproliferative phase that leads to replication stress and DNA damage (Aird et al., 2013; Di Micco et al., 2006), specifically leads to DOT1L upregulation and H3K79 methylation.”
Nikolaev, S. I., Sotiriou, S. K., Pateras, I. S., Santoni, F., Sougioultzis, S., Edgren, H., Almusa, H., Robyr, D., Guipponi, M., Saarela, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-3869 · Cited by 70
The thyroid hormone receptor β induces DNA damage and premature senescence
Zambrano, A., García-Carpizo, V., Gallardo, M. E., Villamuera, R., Gómez-Ferrería, M. A., Pascual, A., Buisine, N., Sachs, L. M., Garesse, R., & Aranda, A. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201305084 · Cited by 68
Wnt signaling potentiates nevogenesis
Pawlikowski, J. S., McBryan, T., van Tuyn, J., Drotar, M. E., Hewitt, R. N., Maier, A. B., King, A., Blyth, K., Wu, H., & Adams, P. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303491110 · Cited by 68
“Although OIS in vitro is preceded by a brief oncogene-induced proliferative burst (49, 50), Wnt-dependent transient bypass of senescence might facilitate this proliferative expansion in vivo, leading to the relatively large size of human nevi.”
BackgroundDietlein, F., Thelen, L., Jokić, M., Jachimowicz, R. D., Ivan, L., Knittel, G., Leeser, U., van Oers, J., Edelmann, W., Heukamp, L. C., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0907 · Cited by 73
DNA replication stress: from molecular mechanisms to human disease
Muñoz, S., & Méndez, J. (2016) · Chromosoma · doi:10.1007/s00412-016-0573-x · Cited by 81
“…upon oncogene activation have also been reported, which may generate DNA damage in different ways: (1) origin refiring events leading to DSBs (Di Micco et al. 2006), (2) accumulation of active forks that rapidly exhaust dNTPs or other replisome components (Bester et al. 2011; Toledo et al.…”
BackgroundTyagi, S., & Herr, W. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.258 · Cited by 75
“The function of E2F1 in the oncogene-induced DDR leading to senescence is not well understood (Bartkova et al, 2006; Di Micco et al, 2006).”
BackgroundWang, Y., Chen, S., Yan, Z., & Pei, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-018-0264-9 · Cited by 56
RAS in cellular transformation and senescence
DeNicola, G. M., & Tuveson, D. A. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70036-x · Cited by 75
DDB1-CUL4 and MLL1 Mediate Oncogene-Induced p16 INK4a Activation
Kotake, Y., Zeng, Y., & Xiong, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2739 · Cited by 69
Kanellis, P., Gagliardi, M., Banáth, J. P., Szilard, R. K., Nakada, S., Galicia, S., Sweeney, F. D., Cabelof, D. C., Olive, P. L., & Durocher, D. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030134 · Cited by 70
“appears to be a hallmark of precancerous and hyperproliferating cells [57,58].”
BackgroundMarkers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
PARP mediated DNA damage response, genomic stability and immune responses
Zong, C., Zhu, T., He, J., Huang, R., Jia, R., & Shen, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33918 · Cited by 74
Khalil, R., Diab‐Assaf, M., & Lemaître, J.-M. (2023) · Cells · doi:10.3390/cells12060915 · Cited by 74
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 74
Myc induced replicative stress response: How to cope with it and exploit it
Rohban, S., & Campaner, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.008 · Cited by 77
Buratta, S., Urbanelli, L., Sagini, K., Giovagnoli, S., Caponi, S., Fioretto, D., Mitro, N., Caruso, D., & Emiliani, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188840 · Cited by 66
Elsallabi, O., Patruno, A., Pesce, M., Cataldi, A., Carradori, S., & Gallorini, M. (2022) · Molecules · doi:10.3390/molecules27030738 · Cited by 67
Cdc6 as a novel target in cancer: Oncogenic potential, senescence and subcellular localisation
Lim, N., & Townsend, P. A. (2020) · International Journal of Cancer · doi:10.1002/ijc.32900 · Cited by 73
“Cdc6 and Senescence The oncogene-induced DNA damage model of cancer development helps explain key features of tumour promotion; the underlying basis for the genomic instability that characterises the chromosomal instability in cancers, and the DDR in premalignant lesions that constitute a barrier to cancer progression…”
BackgroundSenescence in chronic wounds and potential targeted therapies
Wei, X., Li, M., Zheng, Z., Ma, J., Gao, Y., Chen, L., Peng, Y., Yu, S., & Yang, L. (2022) · Burns & Trauma · doi:10.1093/burnst/tkab045 · Cited by 73
“The DDR initiates cellular senescence and cyclin-dependent kinase inhibitors (CDKI) are involved in the process.”
InfluentialCuadrado, M., Gutierrez‐Martinez, P., Swat, A., Nebreda, Á. R., & Fernández-Capetillo, Ó. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0729 · Cited by 81
Interplay between ATM and ATR in the regulation of common fragile site stability
Ozeri-Galai, E., Schwartz, M., Rahat, A., & Kerem, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210849 · Cited by 78
“In addition, overexpression of oncogenes, was shown to result in replication stress and replication-dependent DSBs formation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundSohn, J. J., Schetter, A. J., Yfantis, H. G., Ridnour, L. A., Horikawa, I., Khan, M. A., Robles, A. I., Hussain, S. P., Goto, A., Bowman, E. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044156 · Cited by 66
“Premature cellular senescence halts carcinogenesis by limiting the proliferation of cells in the early stages of carcinogenesis [12,18–20].”
BackgroundRsf-1, a Chromatin Remodeling Protein, Induces DNA Damage and Promotes Genomic Instability
Sheu, J. J., Guan, B., Choi, J., Lin, A. W., Lee, C., Hsiao, Y.-T., Wang, T., Tsai, F., & Shih, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138735 · Cited by 70
Rescue from replication stress during mitosis
Fragkos, M., & Naim, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288322 · Cited by 70
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress
Yang, Y., Gao, Y., Mutter-Rottmayer, L., Zlatanou, A., Durando, M., Ding, W., Wyatt, D. W., Ramsden, D. A., Tanoue, Y., Tateishi, S., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201702006 · Cited by 72
“1 A; Bartkova et al., 2006; Di Micco et al., 2006; Neelsen et al., 2013a).”
InfluentialNCOA4 transcriptional coactivator inhibits activation of DNA replication origins
Bellelli, R., Castellone, M. D., Guida, T., Limongello, R., Dathan, N. A., Merolla, F., Cirafici, A. M., Affuso, A., Masai, H., Costanzo, V., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.031 · Cited by 66
“It is possible that the egg extract system, mimicking the early embryo cell cycle, is able to tolerate high rates of DNA replication, while primary mammalian cells react to unscheduled origin activation with replication stress and DNA damage (Di Micco et al., 2006; Bester et al., 2011).”
Gu, B., Comerci, C. J., McCarthy, D. G., Saurabh, S., Moerner, W. E., & Wysocka, J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.001 · Cited by 68
Rai, P. (2010) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2010.07.010 · Cited by 73
Sidi, R., Pasello, G., Opitz, I., Soltermann, A., Tutic, M., Rehrauer, H., Weder, W., Stahel, R. A., & Felley‐Bosco, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.044 · Cited by 71
Burton, D. G. A., Giribaldi, M. G., Muñoz, A., Halvorsen, K. T., Patel, A., Jordà, M., Perez‐Stable, C., & Rai, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068003 · Cited by 73
“subpopulations [25–27].”
FANCD2 Activates Transcription of TAp63 and Suppresses Tumorigenesis
Park, E., Kim, H., Kim, J. M., Primack, B., Vidal-Cardenas, S. L., Xu, Y., Price, B. D., Mills, A. A., & D’Andrea, A. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.017 · Cited by 70
“In this regard, the Fancd2-Ub tumor-suppressor activity is similar to the prosenescence tumor-suppressor activity observed for other DDR proteins, such as ATM (Bartkova et al., 2006) and CHK2 (Di Micco et al., 2006).”
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C.-W., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 64
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 70
p16INK4a‐induced senescence is disabled by melanoma‐associated mutations
Haferkamp, S., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00422.x · Cited by 59
“Furthermore, the DNA damage checkpoint, which mediates oncogene- induced senescence (Bartkova et al., 2006; Di Micco et al., 2006), was not induced by p16INK4a induction as there was no evidence of increased DNA damage foci in p16INK4a-expressing cells, as marked by H2AX phosphorylation (data not…”
BackgroundActivated p53 induces NF-κB DNA binding but suppresses its transcriptional activation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.021 · Cited by 75
Kaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700935 · Cited by 65
“…DNA damage and activation of the DNA damage response was induced in normal human fibroblasts by expression of gene products such as CDC6, cyclin E, and E2F1 that drive cells into a precocious S phase and by activated oncogenes, including H-RAS (Bartkova et al., 2005, 2006; Di Micco et al., 2006).”
BackgroundPositive and negative effects of cellular senescence during female reproductive aging and pregnancy
Velarde, M. C., & Menon, R. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0018 · Cited by 61
Senescence in polyploid giant cancer cells: A road that leads to chemoresistance
Bharadwaj, D., & Mandal, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.11.002 · Cited by 64
The concerted roles of FANCM and Rad52 in the protection of common fragile sites
Wang, H., Li, S., Oaks, J. J., Ren, J., Li, L., & Wu, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05066-y · Cited by 64
Functional genomic screens identify CINP as a genome maintenance protein
Lovejoy, C. A., Xu, X., Bansbach, C. E., Glick, G. G., Zhao, R., Ye, F., Sirbu, B. M., Titus, L. C., Shyr, Y., & Cortez, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909345106 · Cited by 67
Shimura, T., Ochiai, Y., Noma, N., Oikawa, T., Sano, Y., & Fukumoto, M. (2013) · Cell Cycle · doi:10.4161/cc.23719 · Cited by 67
“5% SDS in instability and acceleration of tumor progression.(21,22) The structure-specific Mus81/Eme1 complex is produced in response to this type of replication perturbation to control genomic stability during DNA replication.”
BackgroundChromatin unfolding by Cdt1 regulates MCM loading via opposing functions of HBO1 and HDAC11-geminin
Wong, P. G., Glozak, M. A., Cao, T. V., Vaziri, C., Seto, E., & Alexandrow, M. G. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13596 · Cited by 77
Idikio, H. (2011) · Journal of Cancer · doi:10.7150/jca.2.107 · Cited by 74
“Cancer senescence occurs via telomere shortening, oxidative stress, and oncogene activation, that can impair cancer progression (33-35).”
BackgroundMetastatic pathways in patients with cutaneous melanoma
Adler, N. R., Haydon, A. M., McLean, C., Kelly, J. W., & Mar, V. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12544 · Cited by 68
“Indeed, both oncogenes and short telomeres may activate DNA damage signalling, representing a common mechanism of senescence induction (Bennett, 2008; Di Micco et al., 2006; Herbig and Sedivy, 2006).”
BackgroundItraconazole targets cell cycle heterogeneity in colorectal cancer
Buczacki, S. J. A., Popova, S., Biggs, E., Koukorava, C., Buzzelli, J., Vermeulen, L., Hazelwood, L., Francies, H., Garnett, M. J., & Winton, D. J. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171385 · Cited by 64
Bouwman, B. A. M., & Crosetto, N. (2018) · Genes · doi:10.3390/genes9120632 · Cited by 72
Exercise Counters the Age-Related Accumulation of Senescent Cells
Zhang, X., Englund, D. A., Aversa, Z., Jachim, S. K., White, T. A., & LeBrasseur, N. K. (2022) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000302 · Cited by 63
“In the context of cancer, overexpression of oncogenic Ras or loss of the tumor suppressor phosphatase and tensin homolog can also trigger the DDR as a consequence of DNA hyperreplication, referred to as mitotic stress (7).”
Backgroundp53 in senescence – it's a marathon, not a sprint
Sheekey, E., & Narita, M. (2021) · FEBS Journal · doi:10.1111/febs.16325 · Cited by 66
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Gu, L., Zhu, Y., Nandi, S. P., Lee, M., Watari, K., Bareng, B., Ohira, M., Liu, Y., Sakane, S., Carlessi, R., et al. (2025) · Nature · doi:10.1038/s41586-024-08317-9 · Cited by 74
Linking replication stress with heterochromatin formation
Nikolov, I., & Taddei, A. (2015) · Chromosoma · doi:10.1007/s00412-015-0545-6 · Cited by 68
Helmbold, H., Komm, N., Deppert, W., & Bohn, W. (2009) · Oncogene · doi:10.1038/onc.2009.222 · Cited by 68
“Furthermore, knockdown of p53 by shRNA impairs oncogene-induced senescence (Di Micco et al., 2006).”
BackgroundSenescent Cells in Growing Tumors: Population Dynamics and Cancer Stem Cells
Porta, C. A. M. L., Zapperi, S., & Sethna, J. P. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002316 · Cited by 68
“Cancer cells are characterized by their persistent proliferation, but just as for normal cells [1] tumor cells can go senescent, halting their growth [2,3].”
BackgroundLimited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression
Efeyan, A., Murga, M., Martinez-Pastor, B., Ortega-Molina, A., Soria, R., Collado, M., Fernandez-Capetillo, O., & Serrano, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005475 · Cited by 58
“Therefore, this is a well-suited cancer model to evaluate in vivo the proposed role of Atm as a general barrier to cancer, including lung cancer [19,20], through the activation of oncogene-induced senescence [21,22].”
BackgroundInhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells
Kumar, S., Peng, X., Daley, J. M., Yang, L., Shen, J., Nguyen, N. C., Bae, G., Niu, H., Peng, Y., Hsieh, H.-J., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.15 · Cited by 63
A mechanism for epigenetic control of DNA replication
Sansam, C. G., Pietrzak, K., Majchrzycka, B., Kerlin, M. A., Chen, J., Rankin, S., & Sansam, C. L. (2018) · Genes & Development · doi:10.1101/gad.306464.117 · Cited by 60
“Cells that simultaneously activate too many forks rapidly accumulate DNA damage, while cells with extreme delays in replication fork initiation display chromosomal instability (Smith et al. 2001; Di Micco et al. 2006).”
Raad, H., Serrano-Sanchez, M., Harfouche, G., Mahfouf, W., Bortolotto, D., Bergeron, V., Kasraian, Z., Dousset, L., Hosseini, M., Taieb, A., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.027 · Cited by 62
“DDR inactivation allows the oncogeneinduced senescence to be bypassed and thus induces the proliferation of oncogene-expressing cells and their transformation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundThe Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Scurr, L. L., Pupo, G. M., Becker, T. M., Lai, K., Schrama, D., Haferkamp, S., Irvine, M., Scolyer, R. A., Mann, G. J., Becker, J. C., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.021 · Cited by 65
“Active oncogenes promote DNA hyper-replication and damage (Bartkova et al., 2006; Di Micco et al., 2006), and immortal melanocytic clones harboring oncogenes have been shown to accumulate additional secondary genetic changes (Sviderskaya et al., 2003; Yu et al., 2009).”
BackgroundPlk1 Inhibition Causes Post-Mitotic DNA Damage and Senescence in a Range of Human Tumor Cell Lines
Driscoll, D. L., Chakravarty, A., Bowman, D., Shinde, V., Lasky, K., Shi, J. Q., Vos, T. J., Stringer, B., Amidon, B., D’Amore, N. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111060 · Cited by 67
“Indeed the DNA double-strand break response has been demonstrated in some settings to be necessary for the induction of senescence [15] [16].”
BackgroundReplication Checkpoint: Tuning and Coordination of Replication Forks in S Phase
Hustedt, N., Gasser, S. M., & Shimada, K. (2013) · Genes · doi:10.3390/genes4030388 · Cited by 75
Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 60
“Discussion Activation of oncogenes induces replication and oxidative stress leading to the accumulation of DNA damage in cells (9, 10, 12).”
BackgroundOhtani, N., Yamakoshi, K., Takahashi, A., & Hara, E. (2010) · Cell Division · doi:10.1186/1747-1028-5-1 · Cited by 62
“Our results strongly suggest that the DNA damage response (DDR) triggered by hyper-cell proliferation [50-52] plays critical role(s) in blocking DNMT1 gene expression, at least partly, through the elevation of the reactive oxygen species (ROS) level in late-stage papillomas [37].”
SOCS1, a novel interaction partner of p53 controlling oncogene-induced senescence
Mallette, F. A., Calabrese, V., Ilangumaran, S., & Ferbeyre, G. (2010) · Aging · doi:10.18632/aging.100163 · Cited by 70
“ATM is an important mediator of the senescence response by activating the p53 pathway, mainly through phosphorylation of the Ser 15 residue [28,45,46].”
Cellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
Common fragile sites: protection and repair
Li, S., & Wu, X. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00392-5 · Cited by 63
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 65
“In fact, senescence may occur independently of age in response to detrimental signals [99], such as genotoxic insults [100], oncogenic [101] and oxidative stresses [102], epigenetic modifications, chromatin remodeling [103], imbalanced proteostasis [104], or mitochondrial dysfunction [104].”
BackgroundRegulation of self‐renewal in normal and cancer stem cells
Falzacappa, M. V. V., Ronchini, C., Reavie, L. B., & Pelicci, P. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08727.x · Cited by 72
The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint
Gandarillas, A. (2012) · Cell Cycle · doi:10.4161/cc.22529 · Cited by 68
Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi
Tran, S. L., Haferkamp, S., Scurr, L. L., Gowrishankar, K., Becker, T. M., Desilva, C., Thompson, J. F., Scolyer, R. A., Kefford, R. F., & Rizos, H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.126 · Cited by 69
Copy number gain and oncogenic activity of YWHAZ/14‐3‐3ζ in head and neck squamous cell carcinoma
Lin, M.-T., Morrison, C. D., Jones, S., Mohamed, N., Bacher, J., & Plass, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24346 · Cited by 68
Hampl, V., Martin, C., Aigner, A. M., Höbel, S., Singer, S., Frank, N., Sarikas, A., Ebert, O., Prywes, R., Gudermann, T. W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202406 · Cited by 70
“The replacement of histone H3 acetylation by methylation in SAHF is another hallmark of senescence (Narita et al, 2003).”
InfluentialPIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311
Yang, J. H., Liu, K., Yang, J. H., Jin, B., Chen, H., Zhan, X., Li, Z., Wang, L., Shen, X., Li, M., et al. (2017) · Oncogene · doi:10.1038/onc.2017.96 · Cited by 63
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.